DK401089A - Farmaceutiske kombinationspraeparater til anvendelse som antineoplastiske laegemidler - Google Patents
Farmaceutiske kombinationspraeparater til anvendelse som antineoplastiske laegemidlerInfo
- Publication number
- DK401089A DK401089A DK401089A DK401089A DK401089A DK 401089 A DK401089 A DK 401089A DK 401089 A DK401089 A DK 401089A DK 401089 A DK401089 A DK 401089A DK 401089 A DK401089 A DK 401089A
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical combinations
- antineoplastic
- antineoplastic medicines
- compounds
- medicines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3827974A DE3827974A1 (de) | 1988-08-18 | 1988-08-18 | Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen |
Publications (2)
Publication Number | Publication Date |
---|---|
DK401089D0 DK401089D0 (da) | 1989-08-15 |
DK401089A true DK401089A (da) | 1990-02-19 |
Family
ID=6361067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK401089A DK401089A (da) | 1988-08-18 | 1989-08-15 | Farmaceutiske kombinationspraeparater til anvendelse som antineoplastiske laegemidler |
Country Status (17)
Country | Link |
---|---|
US (2) | US5578590A (ja) |
EP (1) | EP0359981B1 (ja) |
JP (1) | JPH02108636A (ja) |
KR (1) | KR900002784A (ja) |
AT (1) | ATE91903T1 (ja) |
AU (1) | AU627207B2 (ja) |
CA (1) | CA1330035C (ja) |
DD (1) | DD283938A5 (ja) |
DE (2) | DE3827974A1 (ja) |
DK (1) | DK401089A (ja) |
ES (1) | ES2058420T3 (ja) |
HU (1) | HUT52396A (ja) |
IE (1) | IE64635B1 (ja) |
IL (1) | IL91343A (ja) |
NZ (1) | NZ230323A (ja) |
PT (1) | PT91470A (ja) |
ZA (1) | ZA896287B (ja) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA908936B (en) * | 1989-11-13 | 1991-09-25 | Merrell Dow Pharma | Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones |
ZA908852B (en) * | 1989-11-13 | 1991-09-25 | Merrell Dow Pharma | Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones |
HUT64295A (en) * | 1990-11-02 | 1993-12-28 | Sphinx Pharma Corp | Method for producing bis-(hydroxy-alkyl-amino)-anthraquinone derivatives as well as pharmaceutical preparatives containing them |
US5204370A (en) * | 1990-11-05 | 1993-04-20 | Sphinx Pharmaceuticals Corporation | Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C |
US5141957A (en) * | 1990-11-02 | 1992-08-25 | Sphinx Pharmaceuticals Corporation | 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
EP0539575B1 (en) * | 1991-05-14 | 1997-07-23 | Merrell Pharmaceuticals Inc. | Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones |
WO1993002209A1 (en) * | 1991-07-22 | 1993-02-04 | The Regents Of The University Of California | Methods of designing specific affectors using three-dimensional conformation of enzyme/affector complex |
US5216014A (en) * | 1991-09-10 | 1993-06-01 | Sphinx Pharmaceuticals Corporation | Furo-coumarinsulfonamides as protein kinase C inhibitors |
GB9126209D0 (en) * | 1991-12-10 | 1992-02-12 | Orion Yhtymae Oy | Drug formulations for parenteral use |
US5270310A (en) * | 1991-12-13 | 1993-12-14 | Sphinx Pharmaceuticals Corporation | N-aminoalkyl amide inhibitors of protein kinase C |
US5292737A (en) * | 1992-10-23 | 1994-03-08 | Sphinx Pharmaceuticals Corporation | N,N'-bis(sulfonamido)-2-amino-4-iminonaphthalen-1-ones and N,N'-bis(amido)-2-amino-4-iminonaphthalen-1-ones |
ZA941290B (en) * | 1993-02-26 | 1995-08-25 | Res Dev Foundation | Combination cisplatin/tamoxifen therapy for human cancers |
US5844001A (en) * | 1993-02-26 | 1998-12-01 | Research Development Foundation | Combination platinum chemotherapeutic/antiestrogen therapy for human cancers |
EP0643966A4 (en) * | 1993-03-03 | 1995-08-09 | Kyowa Hakko Kogyo Kk | SENSITIVITY BOOSTER FOR ANTINEOPLASTIC AGENT. |
GB9509572D0 (en) * | 1995-05-11 | 1995-07-05 | Cancer Res Campaign Tech | Cancer therapy |
AU715527B2 (en) * | 1995-06-27 | 2000-02-03 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
US6274576B1 (en) | 1995-06-27 | 2001-08-14 | The Henry Jackson Foundation For The Advancement Of Military Medicine | Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
US5744460A (en) * | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
US6232299B1 (en) | 1996-05-01 | 2001-05-15 | Eli Lilly And Company | Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
US6063814A (en) * | 1997-04-14 | 2000-05-16 | Chang; Richard L. | Phorbol esters as anti-neoplastic and white blood cell elevating agents |
AU765809B2 (en) * | 1998-02-12 | 2003-10-02 | Emory University | Sphingolipid derivatives and their methods of use |
JP3565003B2 (ja) | 1998-04-02 | 2004-09-15 | 日産自動車株式会社 | 自動車の排水構造 |
EP1135193B1 (de) * | 1998-12-04 | 2002-10-30 | Max-Delbrück-Centrum Für Molekulare Medizin | Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten |
CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
AUPQ641100A0 (en) * | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
WO2002002094A2 (en) * | 2000-06-29 | 2002-01-10 | Eli Lilly And Company | Use of a protein kinase c inhibitor to enhance the clinical efficacy of anti-neoplastic chemotherapeutic agents and radiation therapy |
US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
US6693125B2 (en) * | 2001-01-24 | 2004-02-17 | Combinatorx Incorporated | Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders |
US6825229B2 (en) | 2002-03-07 | 2004-11-30 | Blanchette Rockefeller Neurosciences Institute | Methods for Alzheimer's Disease treatment and cognitive enhancement |
US20080004332A1 (en) * | 2002-03-07 | 2008-01-03 | Alkon Daniel L | Methods for alzheimer's disease treatment and cognitive enhancement |
US20050065205A1 (en) | 2002-03-07 | 2005-03-24 | Daniel Alkon | Methods for Alzheimer's disease treatment and cognitive enhance |
US20040116407A1 (en) * | 2002-07-11 | 2004-06-17 | Alexis Borisy | Combinations of drugs for the treatment of neoplasms |
AU2003258061A1 (en) * | 2002-08-02 | 2004-02-23 | Salmedix, Inc. | Therapeutic inhibitionof protein kinases in cancer cells |
US20040175384A1 (en) * | 2003-12-12 | 2004-09-09 | Mohapatra Shyam S. | Protein kinase C as a target for the treatment of respiratory syncytial virus |
US20050080075A1 (en) * | 2003-08-25 | 2005-04-14 | Nichols M. James | Formulations, conjugates, and combinations of drugs for the treatment of neoplasms |
US20050158320A1 (en) * | 2003-11-12 | 2005-07-21 | Nichols M. J. | Combinations for the treatment of proliferative diseases |
US20050100508A1 (en) * | 2003-11-12 | 2005-05-12 | Nichols M. J. | Methods for identifying drug combinations for the treatment of proliferative diseases |
US8592368B2 (en) | 2003-12-19 | 2013-11-26 | University Of South Florida | JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection |
TW201207390A (en) | 2004-05-18 | 2012-02-16 | Brni Neurosciences Inst | Method for screening agent for antidepressant activity |
WO2005115992A1 (en) | 2004-05-23 | 2005-12-08 | Housey Pharmaceuticals, Inc. | Theramutein modulators |
ES2246165B1 (es) * | 2004-07-20 | 2006-12-01 | Universitat De Valencia | Uso combinado del pteroestilbeno y la quercetina para la fabricacion de medicamentos utiles en el tratamiento del cancer. |
US8431110B2 (en) | 2005-05-23 | 2013-04-30 | Hmi Medical Innovations, Llc. | Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators |
WO2007016202A1 (en) | 2005-07-29 | 2007-02-08 | Blanchette Rockefeller Neurosciences Institute | Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory |
US20070112053A1 (en) | 2005-09-16 | 2007-05-17 | Pickett Cecil B | Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor |
CA2631182C (en) * | 2005-11-23 | 2019-08-06 | Gerard M. Housey | Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators |
CN103816127A (zh) * | 2006-11-10 | 2014-05-28 | 阿尔法普托斯有限公司 | 含有三取代甘油化合物的口服剂型 |
ES2391659T3 (es) * | 2006-11-10 | 2012-11-28 | Radioprotect Alphaptose Ug(Haftungsbeschränkt) & Co. Kg | Uso de compuestos de glicerol trisustituido para el tratamiento de lesiones por radiación |
CN101848726A (zh) | 2007-02-09 | 2010-09-29 | 布朗歇特洛克菲勒神经科学研究所 | 苔藓抑素、苔藓抑素类似物和其它相关物质对头部创伤引起的记忆缺陷和脑损伤的疗效 |
US20150366838A1 (en) * | 2014-06-19 | 2015-12-24 | Thomas Christian Lines | Method for treating cancer with a combination of quercetin and a chemotherapy agent |
WO2019169389A1 (en) * | 2018-03-02 | 2019-09-06 | Epicentrx, Inc. | Methods and compositions for treating cancer and sensitizing tumor cells to kinase inhibitors |
WO2020112828A1 (en) | 2018-11-30 | 2020-06-04 | Zwicker Jeffrey I | Compositions and methods for reducing major thrombotic events in cancer patients |
GB202014831D0 (en) | 2020-09-21 | 2020-11-04 | Dc Europa Ltd | Disconnection agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984001506A1 (en) * | 1982-10-13 | 1984-04-26 | Univ Birmingham | Pharmaceutical preparations for use in antitumour therapy |
EP0409845A4 (en) * | 1988-02-23 | 1991-07-03 | U.S. Bioscience | Method for protection from chemotherapeutic side effects |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
-
1988
- 1988-08-18 DE DE3827974A patent/DE3827974A1/de not_active Ceased
-
1989
- 1989-08-10 AT AT89114818T patent/ATE91903T1/de not_active IP Right Cessation
- 1989-08-10 EP EP89114818A patent/EP0359981B1/de not_active Revoked
- 1989-08-10 ES ES89114818T patent/ES2058420T3/es not_active Expired - Lifetime
- 1989-08-10 DE DE8989114818T patent/DE58905028D1/de not_active Revoked
- 1989-08-11 AU AU39550/89A patent/AU627207B2/en not_active Ceased
- 1989-08-15 DD DD89331796A patent/DD283938A5/de not_active IP Right Cessation
- 1989-08-15 DK DK401089A patent/DK401089A/da not_active Application Discontinuation
- 1989-08-16 NZ NZ230323A patent/NZ230323A/en unknown
- 1989-08-17 ZA ZA896287A patent/ZA896287B/xx unknown
- 1989-08-17 IE IE264689A patent/IE64635B1/en not_active IP Right Cessation
- 1989-08-17 PT PT91470A patent/PT91470A/pt not_active Application Discontinuation
- 1989-08-17 IL IL9134389A patent/IL91343A/en not_active IP Right Cessation
- 1989-08-17 HU HU894234A patent/HUT52396A/hu unknown
- 1989-08-18 KR KR1019890011848A patent/KR900002784A/ko not_active Application Discontinuation
- 1989-08-18 CA CA000608760A patent/CA1330035C/en not_active Expired - Fee Related
- 1989-08-18 JP JP1211525A patent/JPH02108636A/ja active Pending
-
1994
- 1994-10-07 US US08/319,478 patent/US5578590A/en not_active Expired - Fee Related
-
1995
- 1995-06-05 US US08/464,343 patent/US5770593A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DD283938A5 (de) | 1990-10-31 |
DE3827974A1 (de) | 1990-02-22 |
ZA896287B (en) | 1990-05-30 |
KR900002784A (ko) | 1990-03-23 |
EP0359981B1 (de) | 1993-07-28 |
AU3955089A (en) | 1990-02-22 |
IE64635B1 (en) | 1995-08-09 |
US5770593A (en) | 1998-06-23 |
NZ230323A (en) | 1992-05-26 |
AU627207B2 (en) | 1992-08-20 |
DK401089D0 (da) | 1989-08-15 |
US5578590A (en) | 1996-11-26 |
JPH02108636A (ja) | 1990-04-20 |
DE58905028D1 (de) | 1993-09-02 |
ATE91903T1 (de) | 1993-08-15 |
IL91343A (en) | 1996-05-14 |
PT91470A (pt) | 1990-03-08 |
IL91343A0 (en) | 1990-03-19 |
IE892646L (en) | 1990-02-18 |
CA1330035C (en) | 1994-06-07 |
HUT52396A (en) | 1990-07-28 |
EP0359981A1 (de) | 1990-03-28 |
ES2058420T3 (es) | 1994-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK401089D0 (da) | Farmaceutiske kombinationspraeparater til anvendelse som antineoplastiske laegemidler | |
DE3883035D1 (de) | Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen. | |
NO870078D0 (no) | Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse samt legemidler som inneholder de. | |
PT83873A (de) | Arzneimittel mit antitumorwirkung | |
NO179911C (no) | Optisk aktivt 5H-pyrrolo[3,4-bÅpyrazinderivat samt farmasöytiske preparater inneholdende derivatet | |
ES511433A0 (es) | "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas". | |
GR3007202T3 (ja) | ||
DK166256C (da) | Konfektionsforpakninger til laegemiddelkombinationer til indtagelse med tidsintervaller | |
NO180584C (no) | Bisnaftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler, samt farmasöytiske preparater | |
DK303688A (da) | Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
MX9203405A (es) | Compuestos activos para usarse en el tratamiento de tumores. | |
NO862198D0 (no) | 1,8-broforbundne 4-chinolon-3-karboksylsyrer, fremgangsmaate til deres fremstilling, samt legemiddel som inneholder dem, og deres anvendelse til fremstilling av legemiddel. | |
ES1008441Y (es) | Dispositivo para el suministro de al menos dos productos fluibles. | |
FI884240A0 (fi) | Menetelmä paikalliseen käyttöön tarkoitetun farmaseuttisen valmisteen valmistamiseksi | |
NO882065D0 (no) | Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse, samt legemidler som inneholder denne. | |
EP0268135A3 (en) | Coccidiocidal agents | |
DK1001942T3 (da) | Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser | |
DK256689A (da) | 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler | |
PT97052A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue | |
ES1001619Y (es) | Piso transpirable para calzado. | |
ES1007658Y (es) | Piso de yute para calzado. | |
ES1007636Y (es) | Piso para calzado. | |
ES1007579Y (es) | Piso para calzado. | |
MX9203558A (es) | Forma de dosis para administrar nicardipina antagonista de calcio. | |
IT8709514V0 (it) | Strumento a siringa per immissione nei piani sottostanti la cute di prodotti farmaceutici. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |